Research Trial Assessing the Immunogenicity and Safety of Three Meningococal B Vaccine Strategies Among Patients With Asplenia.
Condition: Splenectomy Interventions: Biological: Trumenba®; Biological: Bexsero® Sponsors: Assistance Publique - Hôpitaux de Paris; EUCLID Clinical Trial Platform; Recherche Clinique Paris Descartes Necker Cochin Sainte Anne; CIC 1417 Cochin Pasteur; Innovative clinical research in vaccinologie (I-REIVAC); Institut Pasteur Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2019 Category: Research Source Type: clinical trials